Heart HealthResearch PaperPaywall

Conservative Oxygen After Cardiac Arrest Shows No Benefit Over Standard Care

A major RCT of 1,840 ICU patients finds limiting oxygen after cardiac arrest does not improve survival or functional outcomes.

Thursday, June 11, 2026 0 views
Published in N Engl J Med
A ventilated ICU patient connected to a mechanical ventilator with oxygen tubing and monitoring displays showing SpO2 readings in a hospital critical care unit

Summary

A large randomized clinical trial tested whether carefully limiting oxygen exposure in unresponsive cardiac arrest survivors improves outcomes compared to standard liberal oxygen therapy. Researchers enrolled 1,840 ICU patients across 53 hospitals in Australia, New Zealand, and Ireland. After 180 days, roughly 38–40% of patients in both groups survived with a favorable functional outcome — a difference that was not statistically significant. The study challenges the hypothesis that high oxygen levels after cardiac arrest cause meaningful harm. For clinicians, this suggests that current liberal oxygen practices do not need to change, and aggressive oxygen restriction offers no additional benefit to this critically ill population.

Detailed Summary

Oxygen management after cardiac arrest has been a contested area of critical care medicine. Animal and observational studies have raised concern that excess oxygen — called hyperoxia — may worsen brain injury after resuscitation by generating damaging free radicals. This trial, called LOGICAL, was designed to rigorously test whether a conservative oxygen strategy improves outcomes in unresponsive ICU patients following cardiac arrest.

The trial randomly assigned 1,840 mechanically ventilated adults across 53 ICUs in Australia, New Zealand, and Ireland to either conservative or liberal oxygen therapy. In the conservative group, the upper pulse oximetry alarm was set at 95% SpO2 and clinicians reduced inspired oxygen to room air levels (FiO2 0.21) when tolerated. The liberal group had no upper limit and maintained a minimum FiO2 of 0.30. The primary outcome was survival with a favorable functional outcome at 180 days, defined as a score of 5 or higher on the Extended Glasgow Outcome Scale.

At 180 days, 38.2% of conservative-oxygen patients and 39.7% of liberal-oxygen patients achieved a favorable functional outcome — a relative risk of 0.97 that was not statistically significant (95% CI 0.87–1.09; P=0.65). No adverse events were reported in either group.

These results are clinically significant because they contradict the premise behind oxygen restriction protocols that have gained traction in some ICUs. The lack of benefit from conservative oxygen suggests that the pathophysiology of post-cardiac arrest brain injury may not be meaningfully driven by oxygen exposure within the ranges tested here.

Caveats include that this summary is based on the abstract only, and secondary outcomes, subgroup analyses, and actual SpO2 separation between groups are not yet fully available for review. Nonetheless, this is one of the largest and most rigorous trials on this question to date.

Key Findings

  • No significant difference in 180-day survival with favorable function: 38.2% conservative vs 39.7% liberal oxygen.
  • Relative risk of 0.97 (95% CI 0.87–1.09) confirms conservative oxygen is not superior to standard care.
  • Trial enrolled 1,840 patients across 53 ICUs — one of the largest cardiac arrest oxygen management RCTs to date.
  • No adverse events were reported in either oxygen strategy group.
  • Findings challenge the clinical rationale for strict hyperoxia avoidance protocols post-cardiac arrest.

Methodology

Multicenter, open-label randomized controlled trial across 53 ICUs in Australia, New Zealand, and Ireland enrolling unresponsive, mechanically ventilated adults post-cardiac arrest. Conservative oxygen targeted SpO2 90–95% with FiO2 reduced to 0.21 if tolerated; liberal oxygen had no upper SpO2 cap and a minimum FiO2 of 0.30. Primary outcome was 180-day survival with Extended Glasgow Outcome Scale score ≥5.

Study Limitations

This summary is based on the abstract only, as the full paper is not open access; secondary outcomes, subgroup data, and actual achieved SpO2 separation are unavailable for review. The open-label design may have introduced protocol adherence variability. The findings may not generalize to all cardiac arrest subpopulations, such as those with initial shockable rhythms versus non-shockable rhythms.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.